phentolamine has been researched along with Cardiac Output, Low in 10 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hemodynamic studies were made in 15 patients with chronic low output cardiac failure before and following a single dose of oral phentolamine (150 mg)." | 7.66 | Hemodynamic improvement following a single dose of oral phentolamine. Administration in patients with chronic low output cardiac failure. ( Gunnar, RM; Loeb, HS; Maier, PT; Schreiber, R, 1979) |
| "Hemodynamic studies were made in 15 patients with chronic low output cardiac failure before and following a single dose of oral phentolamine (150 mg)." | 3.66 | Hemodynamic improvement following a single dose of oral phentolamine. Administration in patients with chronic low output cardiac failure. ( Gunnar, RM; Loeb, HS; Maier, PT; Schreiber, R, 1979) |
| " The purpose of the present study was to investigate whether the use of nicardipine (Nc) and phentolamine (Ph) in combination with NE could ameliorate the adverse vasoconstrictive action of NE." | 1.30 | Hemodynamic effects of nicardipine and phentolamine in combination with norepinephrine in a canine low-output-state model. ( Hashiyada, H; Kugimiya, T; Miyagawa, N; Shibata, R; Takagi, M; Yamada, T; Yamauchi, H, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Liu, XF | 1 |
| Cornish, KG | 1 |
| Zucker, IH | 1 |
| Patel, KP | 1 |
| Santos, AC | 1 |
| Alves, MJ | 1 |
| Rondon, MU | 1 |
| Barretto, AC | 1 |
| Middlekauff, HR | 1 |
| Negrão, CE | 1 |
| Novikov, SV | 1 |
| Mareev, VIu | 1 |
| Lemmer, JH | 1 |
| Botham, MJ | 1 |
| McKenney, P | 1 |
| Gerren, RA | 1 |
| Kirsh, MM | 2 |
| Gallagher, KP | 1 |
| Gray, R | 1 |
| Shah, PK | 1 |
| Singh, B | 1 |
| Conklin, C | 1 |
| Matloff, JM | 1 |
| Bove, E | 1 |
| Detmer, M | 1 |
| Hill, A | 1 |
| Knight, P | 1 |
| Shibata, R | 1 |
| Takagi, M | 1 |
| Kugimiya, T | 1 |
| Yamauchi, H | 1 |
| Yamada, T | 1 |
| Hashiyada, H | 1 |
| Miyagawa, N | 1 |
| Schreiber, R | 1 |
| Maier, PT | 1 |
| Gunnar, RM | 1 |
| Loeb, HS | 1 |
| Ito, H | 2 |
| Minatoguchi, S | 2 |
| Watanabe, H | 1 |
| Imai, Y | 1 |
| Koshiji, M | 1 |
| Suzuki, S | 1 |
| Ishimura, K | 1 |
| Hirakawa, S | 1 |
1 review available for phentolamine and Cardiac Output, Low
| Article | Year |
|---|---|
[Adrenergic alpha-receptor blockaders and direct arteriolar vasodilators in treatment of chronic cardiac insufficiency].
Topics: Adrenergic alpha-Antagonists; Arterioles; Cardiac Output, Low; Chronic Disease; Hemodynamics; Humans | 1983 |
9 other studies available for phentolamine and Cardiac Output, Low
| Article | Year |
|---|---|
Effects of nNOS antisense in the paraventricular nucleus on blood pressure and heart rate in rats with heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Blood Pressure; Blotti | 2005 |
Sympathetic activation restrains endothelium-mediated muscle vasodilatation in heart failure patients.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Adult; Cardiac Output, Low; Case-Control Studies; Chron | 2005 |
Norepinephrine plus phentolamine improves regional blood flow during experimental low cardiac output syndrome.
Topics: Animals; Cardiac Output, Low; Cardiopulmonary Bypass; Cerebrovascular Circulation; Coronary Circulat | 1984 |
Low cardiac output states after open heart surgery. Comparative hemodynamic effects of dobutamine, dopamine, and norepinephrine plus phentolamine.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Catecholamines; Dobutamine; Dopamine; Dose-Respons | 1981 |
The use of levarterenol and phentolamine in patients with low cardiac output following open-heart surgery.
Topics: Blood Pressure; Cardiac Output, Low; Cardiac Surgical Procedures; Heart Rate; Humans; Norepinephrine | 1980 |
Hemodynamic effects of nicardipine and phentolamine in combination with norepinephrine in a canine low-output-state model.
Topics: Animals; Cardiac Output, Low; Dogs; Drug Therapy, Combination; Female; Hemodynamics; Male; Myocardia | 1997 |
Hemodynamic improvement following a single dose of oral phentolamine. Administration in patients with chronic low output cardiac failure.
Topics: Administration, Oral; Blood Pressure; Cardiac Output; Cardiac Output, Low; Heart Failure; Heart Rate | 1979 |
[Plasma noradrenaline response to phentolamine in "latent" left-sided heart failure].
Topics: Cardiac Output, Low; Exercise Test; Heart; Heart Function Tests; Humans; Infusions, Intravenous; Nor | 1990 |
Increase in plasma noradrenaline concentration after the administration of phentolamine in the patients with "latent" left-sided heart failure.
Topics: Adult; Aged; Cardiac Output, Low; Epinephrine; Exercise Test; Feedback; Female; Humans; Male; Middle | 1989 |